期刊文献+

白桦酸衍生物抗HIV活性的研究进展 被引量:3

Advances in Research on Betulinic Acid Derivatives as Anti-HIV Agents
原文传递
导出
摘要 白桦酸是天然的羽扇豆烷型三萜类化合物,具有较强的抗HIV活性,且作用机制独特。多年来,为进一步改善白桦酸的理化性质、药动学、生物利用度及抗HIV活性,人们通过对其结构的修饰改造,获得了一系列具抗HIV活性及不同作用机制的白桦酸衍生物。综述通过对白桦酸结构中不同位点的修饰改造所得衍生物的抗HIV活性、作用机制及构效关系。 Betulinic acid is a natural lupine-type triterpene, which possesses potent anti-HI~ activity and a unique mechanism of action. In recent years a series of betulinic acid derivatives with anti-HIV activities and different mechanisms of action have been obtained through structure modifications in order to improve the physico-cbemical properties, pharmacokinetics, bioavailability and anti-HIV activity of betulinic acid. The anti-HIV activities, mechanisms of action and structure-activity relationships of betulinic acid derivatives synthesized through structure modifications at various sites on betulinic acid were reviewed.
出处 《药学进展》 CAS 2013年第8期368-375,共8页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金(No.81273377)
关键词 白桦酸衍生物 结构修饰 抗HIV活性 作用机制 构效关系 betulinic acid derivative structure modification anti-HIV activity mechanism of action structure-activity relationship
  • 相关文献

参考文献25

  • 1Sepkowitz K A. AIDS-the first 20 years [ J ]. N Engl J Med,2001,344( 23 ) : 1764-1772.
  • 2Tilton J C, Doms R W. Entry inhibitors in the treatment of HIV-1 infection[ J]. Antiviral Res ,2010,85 ( 1 ) :91-100.
  • 3Sattentau Q J, Moore P J. Conformational changes induced in the human immunodeficiency virus envelope glycopro- tein by soluble CD4 binding [ J ]. J Exp Med, 1991,174 (2) :407-415.
  • 4Smith J A, Daniel R. Following the path of the virus:the exploitation of host DNA repair mechanisms by retroviruses [ J]. ACS Chem Biol,2006,1 (4) :217-226.
  • 5De Cock K M,Jaffe H W,Curran J W. The evolving epi- demiology of HIV/AIDS [ J ]. AIDS, 2012, 26 ( 10 ) : 1205-1213.
  • 6Barbaro G, Seozzafava A, Mastrolorenzo A, et al. Highly active antiretroviral therapy:current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome [ J ]. Curr Pharm Des, 2005,11 (14) : 1805-1843.
  • 7May M T, Ingle S M. Life expectancy of HIV-positive adults : a review [ J ]. Sex Health,2011,8 (4) :526-533.
  • 8Lataillade M, Chiarella J, Yang R, et al. Prevalence and clinical significance of I-IIV drug resistance mutations by ultra-deep sequencing in antiretroviral-na'tve subjects in the CASTLE study [ J ]. PLoS One,2010,5 (6) : e10952.
  • 9Jakobsen M R, Tolstrup M, Scgaard O S, et al. Transmis- sion of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome[ J ]. Clin Infect Dis, 2010,50 (4) ,566-573.
  • 10Li F,Goila-Gaur R,Salzwedel K,et al. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing [ J ]. Proc Natl Acad Sci USA ,2003,100 ( 23 ) : 13555-13560.

同被引文献27

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部